4//SEC Filing
Elston George 4
Accession 0001562180-25-004193
CIK 0001314102other
Filed
May 26, 8:00 PM ET
Accepted
May 27, 4:08 PM ET
Size
9.0 KB
Accession
0001562180-25-004193
Insider Transaction Report
Form 4
Elston George
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2025-05-25$5.68/sh−2,202$12,507→ 80,848 total - Exercise/Conversion
Restricted Stock Units
2025-05-25−7,500→ 7,500 totalExercise: $0.00→ Common Stock (7,500 underlying) - Exercise/Conversion
Common Stock
2025-05-25+7,500→ 83,050 total
Footnotes (2)
- [F1]No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units.
- [F2]The restricted stock units vest in three ratable annual installments beginning May 25, 2024.
Documents
Issuer
EyePoint Pharmaceuticals, Inc.
CIK 0001314102
Entity typeother
Related Parties
1- filerCIK 0001429932
Filing Metadata
- Form type
- 4
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 4:08 PM ET
- Size
- 9.0 KB